These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7240739)

  • 1. Inhibitory effect of K-76 monocarboxylic acid, an anticomplementary agent, on the C3b inactivator system.
    Hong K; Kinoshita T; Kitajima H; Inoue K
    J Immunol; 1981 Jul; 127(1):104-8. PubMed ID: 7240739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple methods for preparing EAC1,4b,2a,3b and EAC4b,3b with human or guinea pig complement components using an anticomplementary agent, K-76 monocarboxylic acid.
    Hong K; Kinoshita T; Inoue K
    J Immunol; 1981 Jul; 127(1):109-14. PubMed ID: 6909271
    [No Abstract]   [Full Text] [Related]  

  • 3. An anticomplementary agent, K-76 monocarboxylic acid: its site and mechanism of inhibition of the complement activation cascade.
    Hong K; Kinoshita T; Miyazaki W; Izawa T; Inoue K
    J Immunol; 1979 Jun; 122(6):2418-23. PubMed ID: 448130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of the C3b-inactivator on the cell-bound C3b.
    Law SK; Fearon DT; Levine RP
    J Immunol; 1979 Mar; 122(3):759-65. PubMed ID: 448074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement receptors on Raji cells. The presence of a new type of C3 receptor.
    Okuda T; Tachibana T
    Immunology; 1980 Sep; 41(1):159-66. PubMed ID: 7429548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement receptors on guinea pig epidermal Langerhans cells.
    Berman B; Gigli I
    J Immunol; 1980 Feb; 124(2):685-90. PubMed ID: 7356709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement receptor binding of C3b-coated cells treated with C3b inactivator, beta 1H globulin and trypsin.
    Carlo JR; Ruddy S; Studer EJ; Conrad DH
    J Immunol; 1979 Aug; 123(2):523-8. PubMed ID: 88474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of the human complement control protein C3b inactivator.
    Crossley LG; Porter RR
    Biochem J; 1980 Oct; 191(1):173-82. PubMed ID: 6451220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement receptor expression by neoplastic and normal human cells.
    Gaither TA; Magrath IT; Berger M; Hammer CH; Novikovs L; Santaella M; Frank MM
    J Immunol; 1983 Aug; 131(2):899-905. PubMed ID: 6306108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative and quantitative assessment of C3-receptor reactivities on lymphoid and phagocytic cells.
    Schmitt M; Mussel HH; Dierich MP
    J Immunol; 1981 May; 126(5):2042-7. PubMed ID: 7217681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that bovine conglutinin reacts with an early product of C3b degradation, and an improved conglutination assay.
    Linscott WD; Ranken R; Triglia RP
    J Immunol; 1978 Aug; 121(2):658-64. PubMed ID: 98586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage of C4b by C3b inactivator: production of a nicked form of C4b, C4b', as an intermediate cleavage product of C4b by C3b inactivator.
    Nagasawa S; Ichihara C; Stroud RM
    J Immunol; 1980 Aug; 125(2):578-82. PubMed ID: 7391570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of beta 1H for the binding of C3b-coated particles to human lymphoid and phagocytic cells.
    Schmitt M; Mussel HH; Hammann KP; Scheiner O; Dierich MP
    Eur J Immunol; 1981 Oct; 11(10):739-45. PubMed ID: 6458499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulin.
    Lambris JD; Dobson NJ; Ross GD
    J Exp Med; 1980 Dec; 152(6):1625-44. PubMed ID: 6450259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the molecular mechanisms of C3b inactivation and a simplified assay of beta 1H and the C3b inactivator (C3bINA).
    Gaither TA; Hammer CH; Frank MM
    J Immunol; 1979 Sep; 123(3):1195-204. PubMed ID: 469245
    [No Abstract]   [Full Text] [Related]  

  • 16. Cleavage of membrane-bound C3b and C3bi by viable human neutrophils (PMN).
    Gaither TA; Hammer CH; Gadek JE; Katusha K; Santaella M; Frank MM
    Mol Immunol; 1983 Jun; 20(6):623-35. PubMed ID: 6603572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.
    Kazatchkine MD; Fearon DT; Silbert JE; Austen KF
    J Exp Med; 1979 Nov; 150(5):1202-15. PubMed ID: 501288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse C3b/C4b inactivator: purification and properties.
    Kai S; Fujita T; Gigli I; Nussenzweig V
    J Immunol; 1980 Dec; 125(6):2409-15. PubMed ID: 6776193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of an iC3b forming enzyme from peritoneal polymorphonuclear leukocytes of guinea pigs.
    Seya T; Nagasawa S
    Biochem Biophys Res Commun; 1983 Dec; 117(2):413-9. PubMed ID: 6229252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.